In largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR SAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ — Cue Health Inc. (“Cue”) (Nasdaq: HLTH) announced today the preprint publication of an independent clinical study – the…